Language:

Metabolic biomarkers for predicting cardiovascular disease

Vascular health and risk management, 2013-01, Vol.9 (default), p.37-45 [Peer Reviewed Journal]

COPYRIGHT 2013 Dove Medical Press Limited ;COPYRIGHT 2013 Dove Medical Press Limited ;2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Montgomery and Brown, publisher and licensee Dove Medical Press Ltd. 2013 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S30378 ;PMID: 23386789

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Metabolic biomarkers for predicting cardiovascular disease
Author: Montgomery, Jana E ; Brown, Jeremiah R
Subjects: Animals ; Biological markers ; Biomarkers ; Biomarkers - metabolism ; C-Reactive Protein - metabolism ; cardiac biomarkers ; Cardiovascular disease ; Cardiovascular diseases ; Cardiovascular Diseases - diagnosis ; Cardiovascular Diseases - economics ; Cardiovascular Diseases - metabolism ; Cardiovascular Diseases - mortality ; Clinical medicine ; Diagnosis ; Health Care Costs ; Humans ; Physiological aspects ; Predictive Value of Tests ; Prognosis ; Review ; Risk Factors
Is Part Of: Vascular health and risk management, 2013-01, Vol.9 (default), p.37-45
Description: Cardiac and peripheral vascular biomarkers are increasingly becoming targets of both research and clinical practice. As of 2008, cardiovascular-related medical care accounts for greater than 20% of all the economic costs of illness in the United States. In the age of burgeoning financial pressures on the entire health care system, never has it been more important to try to understand who is at risk for cardiovascular disease in order to prevent new events. In this paper, we will discuss the cost of cardiovascular disease to society, clarify the definition of and need for biomarkers, offer an example of a current biomarker, namely high-sensitivity C-reactive protein, and finally examine the approval process for utilizing these in clinical practice.
Publisher: New Zealand: Dove Medical Press Limited
Language: English
Identifier: ISSN: 1178-2048
ISSN: 1176-6344
EISSN: 1178-2048
DOI: 10.2147/VHRM.S30378
PMID: 23386789
Source: GFMER Free Medical Journals
MEDLINE
PubMed Central
DOVE Medical Press Journals
ProQuest Central
DOAJ Directory of Open Access Journals

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Metabolic biomarkers for predicting cardiovascular disease

Searching Remote Databases, Please Wait